Drug Experts

The Molecule Hunt: Chasing Tomorrow's Cures


Paul Richardson

Director Pfizer, San Diego, CA

Ashkan Vaziri

Founder & CEO BioSensics, Boston, MA

Gitte Pedersen

CEO & Co-Founder Genomic Expression, Beverly, MA

Jason S. Wood

Technical Service Manager BASF, Boston, MA

Dong Seok Kim

CEO Aevis Bio Inc., South Korea

Tudor Arvinte

CEO & President Therapeomic Inc., Switzerland

Asmita Khanolkar

Sr. Director SMC Ltd, Boston, MA

Magda Zwierzyna

Scientific Director GSK, Italy

Sudipta Bhattacharya

Director Takeda, Lake Bluff, IL

Masha Kononov

Director BD Ingenza Ltd., Raleigh, NC

Norbert Nagel

Head-Global Phys. Anal. Chem AbbVie, Germany

Matthew Myntti

President Next Science, Jacksonville, FL

David Mead

CEO & Co-Founder Terra Bioforge, Middleton, WI

Emilio Sacristan

CEO Neurospire, Mexico

Nguyen Thi Huong Lien

Co-Founder & CEO Sao Thai Duong JSC, Vietnam

Rebeca Ruiz

Principal Scientist Pion Inc., UK

Priya Hays

CEO Hays Documentation Specialists, LLC, San Mateo, CA

Jontae Sanders

Senior Manager Indelible Solutions, Tallahassee, FL

Kenneth A. Jacobson

Senior Investigator NIH, Bethesda, MA

Pal Pacher

Senior Investigator NIH, Bethesda, MA

Jean-Bernard Durand

Professor, Department of Cardiology MD Anderson Cancer Center, Houston, TX

Madelyne Voorhees

Military Medicine Program Rocky Vista University, Englewood, CO

Jerry Siegel

Clinical Associate Professor Ohio State University, Columbus, OH

James M. Cook

Professor Emeritus University of Wisconsin-Milwaukee, Milwaukee, WI

John Spencer

Sussex Drug Discovery Centre University of Sussex, UK

Mark Turner

Women's & Children's Health University of Liverpool, UK

Tony Moore

School of Life Sciences University of Sussex, UK

Paul Workman

Chief Executive & President The Institute of Cancer Research (ICR), UK

320 Washington St, Newton, MA 02458, United States

+1-512-539-0539

contact@drugrnd.com